Struggling firm is returning Sprout Pharmaceuticals subsidiary to original shareholders to resolve dispute over marketing
The life sciences sector has been gripped by a mergers and acquisition frenzy, and it looks set to continue. But what does it mean for the industry?
Concerns raised over efficacy, side effects and use of advocacy campaigning to influence regulatory decisions
First new drug in a decade approved in Europe as Viagra patent expires
© Royal Society of Chemistry Registered charity number: 207890
Site powered by Webvision Cloud